SMAD2 and breast cancer: Importantly, we found that opioid exposure failed to induce classical migration pathways such as MAPK/ERK, TGF-β/SMAD2/3 or WNT/β-Catenin in breast cancer cells, but activated the migratory JAK1/2–STAT3 axis.